	US 12,077,610 B2
	Peptides and other agents for treating pain and increasing pain sensitivity
Arindam Bhattacharjee, Buffalo, NY (US); and Kerri Pryce, Amherst, NY (US)
Assigned to THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK, Amherst, NY (US)
Filed by The Research Foundation for The State University of New York, Amherst, NY (US)
Filed on Sep. 29, 2022, as Appl. No. 17/956,031.
Application 17/956,031 is a continuation of application No. 16/771,204, granted, now 11,535,649, issued on Dec. 27, 2022, previously published as PCT/US2018/065545, filed on Dec. 13, 2018.
Claims priority of provisional application 62/598,067, filed on Dec. 13, 2017.
Prior Publication US 2023/0046305 A1, Feb. 16, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. C07K 7/08 (2006.01); A61K 38/45 (2006.01); A61K 45/06 (2006.01); A61P 29/00 (2006.01)

CPC C07K 7/08 (2013.01) [A61K 38/45 (2013.01); A61P 29/00 (2018.01); A61K 45/06 (2013.01); C12Y 207/04008 (2013.01)]

10 Claims

1. A method for treating pain comprising:

a) a subject in need of treatment for pain;

b) administering to said subject a therapeutically effective amount of a composition selected from the group consisting of a fifteen amino acid peptide having the sequence of X¹X²X³X⁴X⁵PPSYX⁸X⁹VX¹⁰X¹¹X¹²(SEQ ID NO:114) and a MAGI-1 antisense ribonucleic acid; and

c) reducing said pain of said subject.